Therapy News and Research

RSS

A microbiota-driven mechanism underlies severity of leishmaniasis infection

In a recent study posed to the medRxiv* preprint server, researchers in Brazil and the United States investigated the probable impact of the skin microbiome microbiota on the outcomes of cutaneous leishmaniasis.

8 Feb 2023

Preventing, diagnosing, and treating cardiovascular disease in women

An article published in the journal Medical Clinics of North America provides recent updates on cardiovascular disease prevention, diagnosis, and treatment in women.

8 Feb 2023

Case Western Reserve wins $3.03 million grant to advance novel MRI and software technology for brain tumor diagnosis

Most medical magnetic resonance imaging (MRI) scans are inherently qualitative, which can lead to subjective analysis and inconsistent conclusions.

8 Feb 2023

Pregnancy outcomes after monoclonal antibodies infusion for COVID-19

Researchers evaluated the impact of monoclonal antibodies against SARS-CoV-2 on maternal-fetal health.

8 Feb 2023

Recent findings on T-cell immunity induced by SARS-CoV-2 infection and vaccination in immunocompromised individuals

Researchers discussed studies that explored T-cell immunity induced by SARS-CoV-2 infection and COVID-19 vaccination in cancer patients, individuals with HIV, and recipients of solid organ transplants.

8 Feb 2023

Investigating the association between lipid profile and coronary heart disease by race

In a recent study published in the Journal of the American College of Cardiology, researchers investigated the use of serological high-density lipoprotein cholesterol (HDL-C) values to estimate the risk of coronary heart disease (CHD) among adult Black and White individuals.

8 Feb 2023

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Researchers investigated the B cell and humoral immune responses elicited against inactivated and recombinant SARS-CoV-2 vaccines and their safety profiles in patients with CKD.

8 Feb 2023

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

As the Alzheimer's disease scientific community, patients, and families seek to understand the results of clinical trials of new Alzheimer's treatments, the Alzheimer's Association convened an expert work group to discuss an important and timely issue: the "clinical meaningfulness" of results from these studies.

7 Feb 2023

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

The recent JAMA Network Open study evaluated how the Chantix recall influenced prescribing varenicline and other nicotine dependency medications. For this cross-sectional study, a large US-based national cohort was used. All relevant data between January 1, 2021, and June 30, 2022, was obtained from the national pharmacy benefit database.

7 Feb 2023

IU School of Medicine researchers secure grant to study new treatment method for traumatic brain injury

Indiana University School of Medicine and National Intrepid Center of Excellence (NICoE) researchers are collaborating to study a new treatment method for traumatic brain injury (TBI) thanks to a grant from the United States Department of Defense, Congressionally Directed Medical Research Programs (CDMRP).

7 Feb 2023

Study reports two cases of ocular MPox in HIV-infected patients

Researchers review the symptoms, diagnosis, and treatment of ocular Mpox syndrome in men living with HIV infection.

7 Feb 2023

Novel type of combination therapy shows potential in acute myeloid leukemia

Acute myeloid leukemia (AML) is an aggressive form of cancer that originates in the bone marrow, rapidly spreads to the blood and can quickly cause death if not treated promptly.

7 Feb 2023

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows.

7 Feb 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

Decisions by CVS and Optum panicked thousands of their sickest patients

The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn.

7 Feb 2023

Newly identified gene signature helps assess cancer risk and optimize treatment

In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Program, and team have identified a gene signature that accurately predicts the functioning of P53 variants, important information to assessing cancer risk and optimizing choices for cancer therapeutics.

7 Feb 2023

Study reveals mechanism of a previously unexplained type of cell death

A study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Cell Biology, details a previously unexplained type of cell death called disulfidptosis that could open the door for novel cancer therapeutic strategies.

6 Feb 2023

Therapy News and Research

A microbiota-driven mechanism underlies severity of leishmaniasis infection

Preventing, diagnosing, and treating cardiovascular disease in women

Case Western Reserve wins $3.03 million grant to advance novel MRI and software technology for brain tumor diagnosis

Pregnancy outcomes after monoclonal antibodies infusion for COVID-19

Recent findings on T-cell immunity induced by SARS-CoV-2 infection and vaccination in immunocompromised individuals

Investigating the association between lipid profile and coronary heart disease by race

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

IU School of Medicine researchers secure grant to study new treatment method for traumatic brain injury

Study reports two cases of ocular MPox in HIV-infected patients

Novel type of combination therapy shows potential in acute myeloid leukemia

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Decisions by CVS and Optum panicked thousands of their sickest patients

Newly identified gene signature helps assess cancer risk and optimize treatment

Study reveals mechanism of a previously unexplained type of cell death

Gut hormone receptor polyagonists show promise for obesity and diabetes

What do gut microbiota have to do with Alzheimer's and dementia?

Diet, microbial metabolites, and cytokine levels correlate with depression and anxiety symptoms in obese individuals

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News